Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis

Free Subscription Articles published in J Viral Hepat Retrieve available abstracts of 242 articles: HTML format Text format

Single Articles

February 2010
1. JANG JH , Kim JW, Jeong SH, Myung HJ, et al
   Clevudine for chronic hepatitis B: antiviral response, predictors of response, and development of myopathy.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. RYAN MC , Desmond PV, Slavin JL, Congiu M, et al
   Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. WESTIN J , Hellstrand K, Dhillon AP, Lagging M, et al
   Are FoxP3(+) cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C?
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. KALLMAN JB , Tran S, Arsalla A, Haddad D, et al
   Vietnamese community screening for hepatitis B virus and hepatitis C virus.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. GREBELY J , Raffa JD, Lai C, Kerr T, et al
   Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. FU Y , Wang Y, Xia W, Pybus OG, et al
   New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. MAHBOOBI N , Agha-Hosseini F, Mahboobi N, Safari S, et al
   Hepatitis B virus infection in dentistry: a forgotten topic.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. PATTULLO V , Ravindran NC, Mazzulli T, Wong DK, et al
   Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. PARKES J , Guha IN, Roderick P, Harris S, et al
   Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.
   J Viral Hepat. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MELDAL BH , Bon AH, Prati D, Ayob Y, et al
    Diversity of Hepatitis B virus infecting Malaysian candidate blood donors is driven by viral and host factors.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. ROSENBERG P , Hagen K
    Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. SPRADLING PR , Richardson JT, Buchacz K, Moorman AC, et al
    Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. WITTHOEFT T , Hueppe D, John C, Goelz J, et al
    Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. DUBERG AS , Pettersson H, Aleman S, Blaxhult A, et al
    The burden of hepatitis C in Sweden: a national study of inpatient care.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
15. MAIDA I , Martin-Carbonero L, Sotgiu G, Vispo E, et al
    Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. WILLIAMS MJ , Lang-Lenton M
    Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. TRELOAR C , Newland J, Rance J, Hopwood M, et al
    Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. SGIER C , Mullhaupt B, Gerlach T, Moradpour D, et al
    Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. GODOY MM , Lopes EP, Silva RO, Hallwass F, et al
    Hepatitis C virus infection diagnosis using metabonomics.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. MAWATARI H , Yoneda M, Fujita K, Nozaki Y, et al
    Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. REN X , Xu Z, Liu Y, Li X, et al
    Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.
    J Viral Hepat. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
22. BOOT HJ , Hahne S, Cremer J, Wong A, et al
    Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. GREBELY J , Matthews GV, Petoumenos K, Dore GJ, et al
    Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles   
    
    
    
24. EKSIOGLU EA , Bess JR, Zhu H, Xu Y, et al
    Hepatitis C virus modulates human monocyte-derived dendritic cells.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. MENG XJ
    Recent advances in Hepatitis E Virus.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. SCHINAZI RF , Bassit L, Gavegnano C
    HCV drug discovery aimed at viral eradication.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. LIM AK , Patel N, Eckersley RJ, Cobbold JF, et al
    Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. UDDIN G , Shoeb D, Solaiman S, Marley R, et al
    Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. SHAKER O , Ahmed A, Doss W, Abdel-Hamid M, et al
    MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. TANAKA M , Tanaka H, Tsukuma H, Ioka A, et al
    Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. TSOCHATZIS E , Papatheodoridis GV, Koliaraki V, Hadziyannis E, et al
    Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. WINTERMEYER P , Gehring S, Eken A, Wands JR, et al
    Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. BIRERDINC A , Afendy A, Stepanova M, Younossi I, et al
    Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. LAO TT , Sahota DS, Suen SS, Lau TK, et al
    Chronic hepatitis B virus infection and rubella susceptibility in pregnant women.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. ANTONELLI A , Ferri C, Ferrari SM, Colaci M, et al
    High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. WANG T , Campbell RV, Yi MK, Lemon SM, et al
    Role of Hepatitis C virus core protein in viral-induced mitochondrial dysfunction.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. BORENTAIN P , Colson P, Coso D, Bories E, et al
    Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. REN F , Chen Y, Wang Y, Yan Y, et al
    Comparative serum proteomic analysis of patients with acute-on-chronic liver failure: alpha-1-acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. HOLLINGER FB , Sood G
    Occult hepatitis B virus infection: a covert operation.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
40. JAZAYERI SM , Alavian SM, Carman WF
    Hepatitis B virus: origin and evolution.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. PISCHKE S , Ho H, Urbanek F, Meyer-Olsen D, et al
    Hepatitis E in HIV-positive patients in a low-endemic country.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles   
    
    
    
42. MICHEL L , Villes V, Dabis F, Spire B, et al
    Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. KUKLA M , Zwirska-Korczala K, Gabriel A, Waluga M, et al
    Chemerin, vaspin and insulin resistance in chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. NGUYEN NH , Vutien P, Garcia RT, Trinh H, et al
    Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. TAIT JM , McIntyre PG, McLeod S, Nathwani D, et al
    The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. PINEDA JA , Gonzalez J, Ortega E, Tural C, et al
    Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. JANJUA NZ , Hamza HB, Islam M, Tirmizi SF, et al
    Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. ANANTHAKRISHNAN AN , McGinley EL, Fangman J, Saeian K, et al
    Hepatitis C/HIV co-infection is associated with higher mortality in hospitalized patients with Hepatitis C or HIV.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. CROSS TJ , Calvaruso V, Foxton MR, Manousou P, et al
    A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. MARTIN CM , Welge JA, Shire NJ, Rouster SD, et al
    Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. DIETERICH DT , Rizzetto M, Manns MP
    Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. KANDA T , Gauss-Muller V, Cordes S, Tamura R, et al
    Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. PUTKA B , Mullen K, Birdi S, Merheb M, et al
    The disposition of hepatitis C antibody-positive patients in an urban hospital.
    J Viral Hepat. 2009;16:814-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
54. MENDY ME , Welzel T, Lesi OA, Hainaut P, et al
    Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. CROSS TJ , Calvaruso V, Maimone S, Carey I, et al
    Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. BORTOLETTO G , Scribano L, Realdon S, Marcolongo M, et al
    Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. KUKLA M , Zwirska-Korczala K, Gabriel A, Waluga M, et al
    Visfatin serum levels in chronic hepatitis C patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. IKEZAWA K , Naito M, Yumiba T, Iwahashi K, et al
    Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. TURNER J , Bansi L, Gilson R, Gazzard B, et al
    The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. GIANNINI EG , Basso M, Bazzica M, Contini P, et al
    Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients*
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. CASH WJ , Patterson K, Callender ME, McDougall NI, et al
    Adjuvant therapy used in conjunction with combination therapy for chronic hepatitis C improves sustained virus response rates in genotype 1 patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. JUNG YJ , Kim W, Jeong JB, Kim BG, et al
    Clinical features of acute renal failure associated with hepatitis A virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. SUN HY , Lee HC, Liu CE, Yang CL, et al
    Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunity.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. VAN HOUDT R , Bruisten SM, Geskus RB, Bakker M, et al
    Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. UEDA Y , Takada Y, Marusawa H, Haga H, et al
    Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living-donor liver transplantation.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. COBBOLD JF , Crossey MM, Colman P, Goldin RD, et al
    Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. TAKAKI A , Tatsukawa M, Iwasaki Y, Koike K, et al
    Hepatitis C virus NS4 protein impairs the Th1 polarization of immature dendritic cells.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
68. GRABARCZYK P , Garmiri P, Liszewski G, Doucet D, et al
    Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. LUKASIEWICZ E , Gorfine M, Freedman LS, Pawlotsky JM, et al
    Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. SUEN SS , Lao TT, Sahota DS, Lau TK, et al
    Implications of the relationship between maternal age and parity with hepatitis B carrier status in a high endemicity area.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. REIBERGER T , Ferlitsch A, Sieghart W, Kreil A, et al
    HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. WINSTON A , Garvey L, Scotney E, Yerrakalva D, et al
    Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. COPPOLA N , Masiello A, Tonziello G, Pisapia R, et al
    Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. SIR JU , Kim TY
    Autoantibodies are commonly detected by the AIT test in patients with chronic hepatitis C virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles   
    
    
    
75. CALVARUSO V , Camma C, Di Marco V, Maimone S, et al
    Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. MORISCO F , Stroffolini T, Medda E, Amoruso DC, et al
    Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. KIM YJ , Kim HY, Kim JS, Lee JH, et al
    Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. BORRESEN ML , Olsen OR, Ladefoged K, McMahon BJ, et al
    Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. DELAROCQUE-ASTAGNEAU E , Meffre C, Dubois F, Pioche C, et al
    The impact of the prevention programme of hepatitis C over more than a decade: the French experience.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. MIHM U , Hofmann WP, Welsch C, Polta A, et al
    Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. WANG L , Liu F, Liu YD, Li XY, et al
    Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. BADER T
    Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV co-infected patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles   
    
    
    
83. MILAZZO L , Antinori S
    In vivo effects of fluvastatin on HCV replication in HIV-1 coinfected subjects.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles   
    
    
    
84. LOWRY D , Coughlan B, McCarthy O, Crowe J, et al
    Investigating health-related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. GRAMENZI A , Conti F, Felline F, Cursaro C, et al
    Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. SCHIAVON LL , Carvalho-Filho RJ, Narciso-Schiavon JL, Pinheiro SR, et al
    Prediction of significant liver fibrosis in kidney transplant patients with chronic hepatitis C virus infection: the TX-3 index.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. TAN SS , Abu Hassan MR, Abdullah A, Ooi BP, et al
    Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. ZHU YZ , Zhu R, Fan J, Pan Q, et al
    Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. SANCHEZ-CONDE M , Montes-Ramirez ML, Miralles P, Castro Alvarez JM, et al
    Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. MIYAKE Y , Takaki A, Iwasaki Y, Yamamoto K, et al
    Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. SATHIARAJ E , Chutke M, Mahurkar S, Nagaraja Rao P, et al
    Dietary alterations due to perceptions in acute viral hepatitis lead to sub-optimal calorie intake and increased length of hospitalization.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. NEGRO F , Clement S
    Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. GONG QM , Kong XF, Yang ZT, Xu J, et al
    Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection.
    J Viral Hepat. 2009;16:674-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. NYAMATHI AM , Sinha K, Saab S, Marfisee M, et al
    Feasibility of completing an accelerated vaccine series for homeless adults.
    J Viral Hepat. 2009;16:666-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
95. MAIMONE S , Calvaruso V, Pleguezuelo M, Squadrito G, et al
    An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. IMAI Y , Tamura S, Tanaka H, Hiramatsu N, et al
    Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. WATANABE H , Wells F, Major ME
    Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. RASHKIN S , Rouster S, Goodman ZD, Sherman KE, et al
    T-helper cells and liver fibrosis in hepatitis C virus-monoinfected patients.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. OMLAND LH , Jepsen P, Weis N, Christensen PB, et al
    Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.
    J Viral Hepat. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. MAWATARI H , Yoneda M, Fujita K, Nozaki Y, et al
     Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. MOR Z , Srur S, Dagan R, Rishpon S, et al
     Hepatitis A disease following the implementation of universal vaccination: Who is at risk?
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. CHO SW , Koh KH, Cheong JY, Lee MH, et al
     Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. INOUE Y , Hiramatsu N, Oze T, Yakushijin T, et al
     Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. BEKKER V , Chanock SJ, Yeager M, Hutchinson AA, et al
     Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. REIN DB , Lesesne SB, Leese PJ, Weinbaum CM, et al
     Community-based hepatitis B screening programs in the United States in 2008.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. COREY KE , Mendez-Navarro J, Gorospe EC, Zheng H, et al
     Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. FOSTER GR
     Quality of life considerations for patients with chronic hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. YUKI N , Matsumoto S, Kato M, Yamaguchi T, et al
     Hepatic Toll-like receptor 3 expression in chronic hepatitis C genotype 1 correlates with treatment response to peginterferon plus ribavirin.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. RODRIGUEZ-TORRES M , Sulkowski MS, Chung RT, Hamzeh FM, et al
     Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. TAMORI A , Enomoto M, Kobayashi S, Iwai S, et al
     Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. BOYD A , Lacombe K, Miailhes P, Gozlan J, et al
     Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. JENKE AC , Moser S, Orth V, Zilbauer M, et al
     Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2009
113. SROCZYNSKI G , Esteban E, Conrads-Frank A, Schwarzer R, et al
     Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. LAWSON A
     Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase: do they exist and is this really a group with mild disease?
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. WANG LC , Chen EQ, Cao J, Liu L, et al
     Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. YUAN HJ , Jain M, Snow KK, Gale Jr M, et al
     Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. ALAVIAN SM , Tabatabaei SV
     Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. GISH RG , Chang TT, Lai CL, de Man R, et al
     Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B*
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2009
119. HEIDRICH B , Deterding K, Tillmann HL, Raupach R, et al
     Virological and clinical characteristics of delta hepatitis in Central Europe.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. SAYAN M , Akhan SC, Meric M
     Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. HENDERSON WA , Shankar R, Gill JM, Kim KH, et al
     Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. OHKI T , Tateishi R, Goto E, Sato T, et al
     Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. HIRAMATSU N , Oze T, Yakushijin T, Inoue Y, et al
     Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. OZE T , Hiramatsu N, Yakushijin T, Kurokawa M, et al
     Pegylated interferon alpha-2b (Peg-IFN alpha-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN alpha-2b plus ribavirin.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. THOMPSON AJ , McHutchison JG
     Antiviral resistance and specifically targeted therapy for HCV (STAT-C).
     J Viral Hepat. 2009;16:377-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. LEE JH , Yoon JH, Lee CH, Myung SJ, et al
     Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients.
     J Viral Hepat. 2009;16:444-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2009
127. ACALOVSCHI M , Buzas C, Radu C, Grigorescu M, et al
     Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. ITOSE I , Kanto T, Kakita N, Takebe S, et al
     Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. WIEGAND J , Luz B, Mengelkamp AK, Moog R, et al
     Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. ARENDS JE , Stuart JC, Baak LC, van der Ende ME, et al
     Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. DELTENRE P , Canva V, Nady ME, Francois C, et al
     A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective study.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. TAN LK , Gilleece Y, Mandalia S, Murungi A, et al
     Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. CHOU R , Chan BK
     Error in calculation of indirect analyses.
     J Viral Hepat. 2009;16:376.
     PubMed     Text format     Related articles   
     
     
     
134. THOMAS H
     The journal has great pleasure in welcoming John McHutchison. Editorial.
     J Viral Hepat. 2009;16:299.
     PubMed     Text format     Related articles   
     
     
     April 2009
135. CHANDRA PK , Biswas A, Datta S, Banerjee A, et al
     Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. CHANG TT , Chao YC, Gorbakov VV, Han KH, et al
     Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naive HBeAg-positive patients with chronic hepatitis B.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. SUN QF , Ding JG, Xu DZ, Chen YP, et al
     Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. MARTIN-CARBONERO L , de Ledinghen V, Moreno A, Maida I, et al
     Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. THEIN HH , Yi Q, Heathcote EJ, Krahn MD, et al
     Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. MADEJON A , Vispo E, Bottecchia M, Sanchez-Carrillo M, et al
     Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. ELEFSINIOTIS IS , Pavlidis C, Dimitroulopoulos D, Vezali E, et al
     Differential viral kinetics in treated genotype 4 chronic hepatitis C patients according to ethnicity.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. CHEN ST , Ni YH, Chen PJ, Chen HL, et al
     Low viraemia at enrollment in children with chronic hepatitis C favours spontaneous viral clearance.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. LEHMAN EM , Wilson ML
     Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. VEAZJALALI M , Norder H, Magnius L, Jazayeri SM, et al
     A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis.
     J Viral Hepat. 2009;16:259-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. ALATRAKCHI N , Koziel M
     Regulatory T cells and viral liver disease.
     J Viral Hepat. 2009;16:223-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
146. HANSEN N , Obel N, Christensen PB, Krarup H, et al
     Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. QI C , Zhu W, Niu Y, Zhang HG, et al
     Detection of hepatitis B virus markers using a biosensor based on imaging ellipsometry.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. DERBALA M , Rizk N, Al-Kaabi S, Amer A, et al
     Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. REDDY KR , Messinger D, Popescu M, Hadziyannis SJ, et al
     Peginterferon alfa-2a (40kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. MELLO IM , Thumann C, Schvoerer E, Soulier E, et al
     Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. RUSSELL RS , Kawaguchi K, Meunier JC, Takikawa S, et al
     Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. NGUYEN VT , Law MG, Dore GJ
     Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. MARTIN-BLONDEL G , Gales A, Bernad J, Cuzin L, et al
     Low interleukin-10 production by monocytes of patients with a self-limiting hepatitis C virus infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. LI C , Lu L, Zhang X, Murphy D, et al
     Entire genome sequences of two new HCV subtypes, 6r and 6s, and characterization of unique HVR1 variation patterns within genotype 6.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. PENE V , Hernandez C, Vauloup-Fellous C, Garaud-Aunis J, et al
     Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. WILLIAMS MJ , Lawson A, Neal KR, Ryder SD, et al
     Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. TOMA S , Yamashiro T, Arakaki S, Shiroma J, et al
     Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. IWASA M , Hara N, Miyachi H, Tanaka H, et al
     Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. NGUYEN MH , Keeffe EB
     Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.
     J Viral Hepat. 2009;16:149-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. CRAINE N , Parry J, O'Toole J, D'Arcy S, et al
     Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service.
     J Viral Hepat. 2009;16:219-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
161. LONG Y , Chen E, Liu C, Huang F, et al
     The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. CASTERA L
     Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. VERA-OTAROLA J , Barria MI, Leon U, Marsac D, et al
     Hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells of treatment naive chronically infected patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. LIBRI NA , Barker SJ, Rosenberg WM, Semper AE, et al
     A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. JOHN-BAPTISTE A , Varenbut M, Lingley M, Nedd-Roderique T, et al
     Treatment of hepatitis C infection for current or former substance abusers in a community setting.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. VAN DEN BERG CH , van de Laar TJ, Kok A, Zuure FR, et al
     Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. KIM SJ , Kim JH, Sun JM, Kim MG, et al
     Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. CANNON NA , Donlin MJ, Mayes LM, Lyra AC, et al
     Evidence for action of ribavirin through the hepatitis C virus RNA polymerase.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. PRASAD L , Spicher VM, Negro F, Rickenbach M, et al
     Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. CHANG ML , Sung KF, Sheen IS, Lin SM, et al
     A liver slice culture-based ex vivo assay to predict the outcome of antiviral therapy for chronic hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. GISMONDI MI , Becker PD, Diaz Carrasco JM, Guzman CA, et al
     Evolution of hepatitis C virus hypervariable region 1 in immunocompetent children born to HCV-infected mothers.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. KHUROO MS , Kamili S, Khuroo MS
     Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. GREBELY J , Raffa JD, Lai C, Krajden M, et al
     Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. CHEUNG KJ , Tilleman K, Deforce D, Colle I, et al
     The HCV serum proteome: a search for fibrosis protein markers.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. IKEDA K , Kobayashi M, Someya T, Saitoh S, et al
     Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. VAN DEN BERG CH , Ruys TA, Nanlohy NM, Geerlings SE, et al
     Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. NOMURA H , Miyagi Y, Tanimoto H, Ishibashi H, et al
     Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. IDILMAN R , Kaymakoglu S, Oguz Onder F, Ahishali E, et al
     A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. YANG YF , Zhao W, Zhong YD, Xia HM, et al
     Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. ROTMAN Y , Katz L, Cohen M, Cohen-Ezra O, et al
     Low weight predicts neutropenia and peginterferon alfa-2a dose reductions during treatment for chronic hepatitis C.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. MORENO S , Garcia-Samaniego J, Moreno A, Ortega E, et al
     Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. PHAM TN , Mercer SE, Michalak TI
     Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. MILAZZO L , Meroni L, Galazzi M, Cesari M, et al
     Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. TOMIYAMA D , Inoue E, Osawa Y, Okazaki K, et al
     Serological evidence of infection with hepatitis E virus among wild Yezo-deer, Cervus nippon yesoensis, in Hokkaido, Japan.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. MAVROGIANNAKI A , Karamanos B, Manesis EK, Papatheodoridis GV, et al
     Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. WADA M , Marusawa H, Yamada R, Nasu A, et al
     Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. TARANTINO G , Marco VD, Petta S, Almasio PL, et al
     Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. CROSS TJ , Quaglia A, Hughes S, Joshi D, et al
     The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. SANVISENS A , Serra I, Tural C, Tor J, et al
     Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. ONG SC , Lim SG, Li SC
     Cultural adaptation and validation of a questionnaire for use in hepatitis B patients.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. ARTEAGA A , Carrasco-Garrido P, de Andres AL, de Miguel AG, et al
     Trends of hepatitis A hospitalizations and costs associated with the hospitalization in Spain (2000-2005).
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. TSENG GY , Yang KY
     Kinetics of hepatitis B virus load and haemodialysis: a prospective study.
     J Viral Hepat. 2009.
     PubMed     Text format     Related articles   
     
     
     January 2009
193. PANESSA C , Hill WD, Giles E, Yu A, et al
     Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia.
     J Viral Hepat. 2009;16:64-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. ONG SC , Lim SG, Li SC
     How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore.
     J Viral Hepat. 2009;16:53-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
195. VIGANO M , Lampertico P, Facchetti F, Lunghi G, et al
     Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine.
     J Viral Hepat. 2008;15:922-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. KENNEDY PT , Gehring AJ, Nowbath A, Selden C, et al
     The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis.
     J Viral Hepat. 2008;15:901-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. CASTANEDA-SCEPPA C , Bermudez OI, Wanke C, Forrester JE, et al
     Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus.
     J Viral Hepat. 2008;15:878-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. REGEARD M , Trotard M, Lepere C, Gripon P, et al
     Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor.
     J Viral Hepat. 2008;15:865-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. FARQUHAR MJ , McKeating JA
     Primary hepatocytes as targets for Hepatitis C virus replication.
     J Viral Hepat. 2008;15:849-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
200. SUTTON AJ , Hope VD, Mathei C, Mravcik V, et al
     A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.
     J Viral Hepat. 2008;15:809-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
201. ALVAREZ-LAJONCHERE L , Shoukry NH, Gra B, Amador-Canizares Y, et al
     Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. PATEL K , Benhamou Y, Yoshida EM, Kaita KD, et al
     An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
203. ROSS RS , Viazov S, Clauberg R, Wolters B, et al
     Lack of de novo hepatitis C virus infections and absence of nosocomial transmissions of GB virus C in a large cohort of German haemodialysis patients.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
204. GONZALEZ SA , Fiel MI, Sauk J, Canchis PW, et al
     Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
205. POYNARD T , Ngo Y, Marcellin P, Hadziyannis S, et al
     Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. FOUCHER J , Reiller B, Jullien V, Leal F, et al
     FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. VERGNIOL J , Foucher J, Castera L, Bernard PH, et al
     Changes of non-invasive markers and FibroScan values during HCV treatment.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. FRIEDRICH-RUST M , Theobald J, Zeuzem S, Bojunga J, et al
     Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. MESHKAT Z , Audsley M, Beyer C, Gowans EJ, et al
     Reverse genetic analysis of a putative, influenza virus M2 HXXXW-like motif in the p7 protein of hepatitis C virus.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. XU WM , Cui YT, Wang L, Yang H, et al
     Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. CHOTIYAPUTTA W , Lok AS
     Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles   
     
     
     
212. CEYHAN M , Yildirim I, Kurt N, Uysal G, et al
     Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
     J Viral Hepat. 2008;15 Suppl 2:69-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. FERREIRA CT , Vieira SM, Kieling CO, Silveira TR, et al
     Hepatitis A acute liver failure: follow-up of paediatric patients in southern Brazil.
     J Viral Hepat. 2008;15 Suppl 2:66-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. CHODICK G , Heymann AD, Ashkenazi S, Kokia E, et al
     Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
     J Viral Hepat. 2008;15 Suppl 2:62-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. FISENKA EG , Germanovich FA, Glinskaya IN, Lyabis OI, et al
     Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
     J Viral Hepat. 2008;15 Suppl 2:57-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. DOMINGUEZ A , Oviedo M, Carmona G, Jansa JM, et al
     Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
     J Viral Hepat. 2008;15 Suppl 2:51-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. VACCHINO MN
     Incidence of Hepatitis A in Argentina after vaccination.
     J Viral Hepat. 2008;15 Suppl 2:47-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. MOISSEEVA AV , Marichev IL, Biloschitchkay NA, Pavlenko KI, et al
     Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.
     J Viral Hepat. 2008;15 Suppl 2:43-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
219. SHLIAKHTENKO L , Plotnikova V, Levakova I, Rubis L, et al
     Modern epidemiology of hepatitis A in the north-western region of the Russian Federation.
     J Viral Hepat. 2008;15 Suppl 2:38-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. XU ZY , Wang XY, Liu CQ, Li YT, et al
     Decline in the risk of hepatitis A virus infection in China, a country with booming economy and changing lifestyles.
     J Viral Hepat. 2008;15 Suppl 2:33-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
221. TOSTI ME , Spada E, Romano L, Zanetti A, et al
     Acute hepatitis A in Italy: incidence, risk factors and preventive measures.
     J Viral Hepat. 2008;15 Suppl 2:26-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
222. VITRAL CL , Souto FJ, Gaspar AM
     Changing epidemiology of hepatitis A in Brazil: reassessing immunization policy.
     J Viral Hepat. 2008;15 Suppl 2:22-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. GENTILE A
     The need for an evidence-based decision-making process with regard to control of hepatitis A.
     J Viral Hepat. 2008;15 Suppl 2:16-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
224. HENDRICKX G , Van Herck K, Vorsters A, Wiersma S, et al
     Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology.
     J Viral Hepat. 2008;15 Suppl 2:1-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. 
     Proceedings of the first global meeting on hepatitis A virus infection, 2007, Miami, Florida, USA.
     J Viral Hepat. 2008;15 Suppl 2:1-72.
     PubMed     Text format     Related articles   
     
     
     September 2008
226. REIJNDERS JG , Leemans WF, Hansen BE, Pas SD, et al
     On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. LU L , Zhang HY, Yueng YH, Cheung KF, et al
     Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. RAPTOPOULOU M , Papatheodoridis G, Antoniou A, Ketikoglou J, et al
     Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
229. ARANKALLE VA , Ramakrishnan J
     Simian hepatitis A virus derived from a captive rhesus monkey in India is similar to the strain isolated from wild African green monkeys in Kenya.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
230. ZEUZEM S , Berg T, Moeller B, Hinrichsen H, et al
     Expert opinion on the treatment of patients with chronic hepatitis C.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
231. ZHOU J , Smith DK, Lu L, Poon VK, et al
     A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
232. DE FELIPE B , Leal M, Soriano-Sarabia N, Gutierrez A, et al
     HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
233. ANDRIULLI A , Cursaro C, Cozzolongo R, Iacobellis A, et al
     Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
234. CORNBERG M , Protzer U, Dollinger MM, Petersen J, et al
     The German guideline for the management of hepatitis B virus infection: short version.
     J Viral Hepat. 2008;15 Suppl 1:1-21.
     PubMed     Text format     Related articles   
     
     
     July 2008
235. XIROUCHAKIS E , Triantos C, Manousou P, Sigalas A, et al
     Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
236. SRIVASTAVA R , Aggarwal R, Bhagat MR, Chowdhury A, et al
     Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
237. CHAN HL , Wong GL, Choi PC, Chan AW, et al
     Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
238. HOFMANN WP , Kronenberger B, Bojunga J, Stamm B, et al
     Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
239. FABRIZI F , Lunghi G, Alongi G, Aucella F, et al
     Kinetics of hepatitis B virus load and haemodialysis: a prospective study.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
240. YEH CT , Tang JH, Hsu CW, Chen YC, et al
     Expression of hepatitis B virus nuclear core antigen in young cirrhotic patients is associated with an unfavourable long-term outcome.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
241. ZEREMSKI M , Shu MA, Brown Q, Wu Y, et al
     Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
242. LALAZAR G , Pappo O, Hershcovici T, Hadjaj T, et al
     A continuous (13)C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT.
     J Viral Hepat. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: